[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Abbott Laboratories Stock: Analyst Estimates & Ratings

With a market cap of $151.6 billion, Abbott Laboratories (ABT) is a global healthcare company that develops, manufactures, and sells a wide range of products across pharmaceuticals, diagnostics, nutrition, and medical devices. It provides innovative healthcare solutions including generic medicines, diagnostic systems, nutritional products, cardiovascular devices, and diabetes care technologies worldwide.

Shares of the Abbott Park, Illinois-based company have underperformed the broader market over the past 52 weeks. ABT stock has decreased 35% over this time frame, while the broader S&P 500 Index ($SPX) has gained 30.3%. Moreover, the stock has declined 30.6% on a YTD basis, compared to SPX's 7.2% rise.

Fundamentals

See More
  • Market Capitalization, $K 151,555,152
  • Shares Outstanding, K 1,741,813
  • Annual Sales, $ 44,328 M
  • Annual Income, $ 6,524 M
  • EBIT $ 9,389 M
  • EBITDA $ 12,505 M
  • 60-Month Beta 0.65
  • Price/Sales 3.39
  • Price/Cash Flow 12.35
  • Price/Book 2.85

Options Overview Details

View History
  • Implied Volatility 27.89% (+1.18%)
  • Historical Volatility 27.07%
  • IV Percentile 89%
  • IV Rank 63.13%
  • IV High 34.27% on 03/27/26
  • IV Low 16.97% on 08/12/25
  • Expected Move (DTE 7) 2.23 (2.64%)
  • Put/Call Vol Ratio 3.14
  • Today's Volume 35,056
  • Volume Avg (30-Day) 22,401
  • Put/Call OI Ratio 0.76
  • Today's Open Interest 235,107
  • Open Int (30-Day) 192,701
  • Expected Range 82.09 to 86.55

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.28
  • Number of Estimates 7
  • High Estimate $1.28
  • Low Estimate $1.27
  • Prior Year $1.26
  • Growth Rate Est. (year over year) +1.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
84.08 +0.29%
on 05/08/26
103.32 -18.39%
on 04/09/26
-19.24 (-18.58%)
since 04/08/26
3-Month
84.08 +0.29%
on 05/08/26
116.82 -27.82%
on 02/27/26
-26.51 (-23.92%)
since 02/06/26
52-Week
84.08 +0.29%
on 05/08/26
139.06 -39.36%
on 06/24/25
-49.68 (-37.07%)
since 05/08/25

Most Recent Stories

More News
Abbott Laboratories Stock: Analyst Estimates & Ratings

While Abbott Laboratories has underperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

ABT : 84.32 (-3.09%)
XLV : 143.49 (-0.85%)
$SPX : 7,398.93 (+0.84%)
Wall Street Is High on These 3 Dividend Aristocrats

We take a look at three top-rated companies that have raised their dividends without interruption for decades.

LIN : 493.16 (-0.14%)
TGT : 125.25 (-0.50%)
ABT : 84.32 (-3.09%)
WMT : 130.43 (+0.18%)
Abbott Stock Is Trading at 52-Week Lows but Insiders Are Gobbling Up Shares of This Blue-Chip Dividend Payer

Abbott’s business and dividend story remain intact even as the stock trades near 52‑week lows.

ABT : 84.32 (-3.09%)
$SPX : 7,398.93 (+0.84%)
$SRHC : 1,672.11 (-0.86%)
AbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead?

AbbVie's early 2026 price pullback is an irresistable opportunity for buy-and-hold investors looking for income and compounding opportunities.

ABT : 84.32 (-3.09%)
ABBV : 201.55 (-0.57%)
Abbott receives FDA clearance and CE Mark for next-generation Ultreonâ„¢ 3.0 AI-powered coronary imaging platform

ABBOTT PARK, Ill. , April 28, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next-generation Ultreonâ„¢...

ABT : 84.32 (-3.09%)
Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026

ABBOTT PARK, Ill. , April 25, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced new late-breaking data from four trials that demonstrate strong clinical outcomes within its pulsed field ablation...

ABT : 84.32 (-3.09%)
This Boring Dividend King Might Be the Safest Pick to Add to Your Portfolio

Abbott Labs is a balance of income and growth.

ABT : 84.32 (-3.09%)
$SPX : 7,398.93 (+0.84%)
New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test

ABBOTT PARK, Ill. , April 17, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) will present new data at the American Association for Cancer Research (AACR) Annual Meeting 2026 demonstrating continued advancements...

ABT : 84.32 (-3.09%)
Abbott Stock Crash: Rebound Could Be Coming Fast

Abbott Laboratories' stock price sell-off is overextended in mid-April, creating an opportunity that income investors will not want to miss.

ABT : 84.32 (-3.09%)
Abbott Labs’ Financial Results Narrowly Beat Forecasts

Abbott Laboratories (ABT) has reported first-quarter financial results that narrowly beat Wall Street’s ...

ABT : 84.32 (-3.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

Relative Strength is below 30%. The market is in oversold territory. Watch for a potential trend reversal.

See More Share

Business Summary

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures...

See More

Key Turning Points

3rd Resistance Point 89.62
2nd Resistance Point 88.47
1st Resistance Point 86.39
Last Price 84.32
1st Support Level 83.16
2nd Support Level 82.01
3rd Support Level 79.93

See More

52-Week High 139.06
Fibonacci 61.8% 118.06
Fibonacci 50% 111.57
Fibonacci 38.2% 105.08
Last Price 84.32
52-Week Low 84.08

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.